Researchers has found that elevated levels of NfL in the blood of multiple sclerosis (MS) patients could signal worsening disability within the next one to two years. This first-of-its-kind study pinpoints a crucial timeframe for potential interventions.
By analyzing data from nearly 1,900 patients over a decade, the team discovered that high NfL levels correlate with a significant risk of disability progression, with or without relapse.
These findings underscore the importance of NfL as an early biomarker for nerve damage and could pave the way for preemptive treatments in MS.
https://neurosciencenews.com/nfl-bio...ression-25161/
Comment